Материалы VI межрегиональной научной конференции, 4–6 сентября 2019
91
Lvova M.N., Tangkawattana S., Balthaisong S., Katokhin A.V., Mordvinov V.A., Sripa B. 2012.
Comparative histopathology of
Opisthorchis felineus and
Opisthorchis viverrini in a hamster model:
an implication of high pathogenicity of the European liver fluke // Parasitol Int. 61(1): 167–172.
doi: 10.1016/j.parint.2011.08.005.
Lvova M., Zhukova M., Kiseleva E., Mayboroda O., Hensbergen P., Kizilova E., Ogienko A.,
Besprozvannykh V., Sripa B., Katokhin A., Mordvinov V. 2016. Hemozoin is a product of heme
detoxification in the gut of the most medically important species of the family Opisthorchiidae // Int
J Parasitol. 46(3): 147–156. doi: 10.1016/j.ijpara.2015.12.003.
Maksimova, GA, Pakharukova, MY, Kashina, EV, Zhukova, NA, Kovner, AV, Lvova, MN, Katokhin,
AV, Tolstikova, TG, Sripa, B, Mordvinov, VA.
Effect of Opisthorchis felineus infection and
dimethylnitrosamine administration on the induction of cholangiocarcinoma in Syrian hamsters.
Parasitol Int. 2017. 66, 458-463. doi:10.1016/j.parint.2015.10.002.
Moll R., Divo M., Langbein L. 2008. The human keratins: biology and pathology // Histochem Cell
Biol. 129(6): 705–733. doi: 10.1007/s00418-008-0435-6.
Hongsrichan N., Rucksaken R., Chamgramol Y., Pinlaor P., Techasen A., Yongvanit P., Khuntikeo N.,
Pairojkul C., Pinlaor S. 2013. Annexin A1: A new immunohistological marker of
cholangiocarcinoma // World J Gastroenterol. 19(16): 2456–2465. doi: 10.3748/wjg.v19.i16.2456.
Khoontawad J., Hongsrichan N., Chamgramol Y., Pinlaor P., Wongkham C., Yongvanit P.,
Pairojkul C., Khuntikeo N., Roytrakul S., Boonmars T., Pinlaor S. 2014. Increase of exostosin 1
in plasma as a potential biomarker for opisthorchiasis-associated cholangiocarcinoma // Tumour
Biol. 35(2): 1029–1039. doi: 10.1007/s13277-013-1137-9.
Korita P.V., Wakai T., Ajioka Y., Inoue M., Takamura M., Shirai Y., Hatakeyama K. 2010. Aberrant
expression of vimentin correlates with dedifferentiation and poor prognosis in patients with
intrahepatic cholangiocarcinoma // Anticancer Res. 30(6): 2279–2285.
Potter E.A., Proskurina A.S., Ritter G.S., Dolgova E.V., Nikolin V.P., Popova N.A., Taranov O.S.,
Efremov Y.R., Bayborodin S.I., Ostanin A.A., Chernykh E.R., Kolchanov N.A., Bogachev S.S.
2018. Efficacy of a new cancer treatment strategy based on eradication of tumor-initiating stem
cells in a mouse model of Krebs-2 solid adenocarcinoma // Oncotarget. 9(47): 28486–28499. doi:
10.18632/oncotarget.25503.
Достарыңызбен бөлісу: